Prevalence of five previously reported and recurrentBRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families-Reference-Cited by-同舟云学术

Prevalence of five previously reported and recurrentBRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families

Published:2005 Issue:3 Volume:43 Page:309-313
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Hendrickson Brant C.,Judkins Thaddeus,Ward Benjamin D.,Eliason Kristilyn,Deffenbaugh Amie E.,Burbidge Lynn Anne,Pyne Kristin,Leclair Benoît,Ward Brian E.,Scholl Thomas

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference19 articles.

1. Real-time PCR-based gene dosage assay for detecting BRCA1 rearrangements in breast-ovarian cancer families

2. The Exon 13 Duplication in the BRCA1 Gene Is a Founder Mutation Present in Geographically Diverse Populations

3. Rapid detection of novelBRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments

4. Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1

5. Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Concordance between Germline and Tumour BRCA1/2 Status in Epithelial Ovarian Cancer;Cancers;2023-12-29

2. Molecular profiling of BRCA1 and BRCA2 genes in Turkish patients with early-onset breast cancer;Egyptian Journal of Medical Human Genetics;2023-10-14

3. The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next‐generation sequencing;Genes, Chromosomes and Cancer;2023-05-24

4. Genes and cancer: Genetic counselling and clinical management;DiSaia and Creasman Clinical Gynecologic Oncology;2023

5. Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective;Molecular Genetics and Genomics;2022-04-22